drugset
drugset / Trial / NCT04052711

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

NCT04052711 ↗

Phase 1 Completed 233 enrolled Vyne Therapeutics Inc.
NaSingle-groupOpen-labelOther

Summary

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

Timeline

Start
2016-09-08
Primary completion
2016-11-19
Completion
2016-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject FMX-101 Unknown — —

Indications

No indication recorded.